Head & Neck Cancers

Ezra Cohen, MD; Robert Ferris, MD, PhD, FACS; and Jared Weiss, MD, provide a comprehensive overview of diagnosis and treatment of advanced head and neck squamous cell carcinoma (HNSCC), including multidisciplinary care and emerging evidence surrounding novel therapies. Treatment approaches to HPV-positive and HPV-negative tumors are explored.

Although most patients with differentiated thyroid cancer have an excellent prognosis, a subset of these patients will develop a more aggressive, refractory phenotype. This OncLive Peer Exchange moderated by R. Michael Tuttle, MD, focuses the latest information about how to use available therapies and the path forward to a more personalized approach for patients. The expert panel of endocrinologists and oncologists includes Marcia S. Brose, MD, PhD; Naifa Busaidy, MD, FACP, FACE; Eric J. Sherman, MD; and Francis Paul Worden, MD.
View Now